The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2026
APTEVO THERAPEUTICS INC.
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of October 2026
Commission File Number: 001-06439
SONY GROUP CORPORATION
(Translation of registrant’s name into English)
1-7-1 KONAN, MINATO-KU, TOKYO, 108-0075, JAPAN
(Address of principal executive offices)
The registrant files annual reports... (continue reading...)
More SEC Filings
View Older Stories-
Form 13F-HR Barry Investment Advisor For: Sep 30
-
Form 13F-HR TruNorth Capital Managem For: Sep 30
-
Form 13F-HR Financial Advisory Corp For: Sep 30
-
Form 13F-HR BCO Wealth Management For: Sep 30
-
Form S-8 POS Waldencast plc
-
Form 424B5 IonQ, Inc.
-
Form 13F-HR Upper Left Wealth Manage For: Sep 30
-
Form 8-K Integer Holdings Corp For: Oct 14
-
Form 13F-HR ATX Financial Planning, For: Sep 30
-
Form 8-K Evolution Metals & Techn For: Oct 14
-
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 14
-
Form 13F-HR Oliver Luxxe Assets LLC For: Sep 30
-
Form 424B5 IonQ, Inc.
-
Form ABS-15G Hildene Opportunities For: Sep 01
-
Form 8-K Eagle Point Credit Co For: Oct 14
-
Form 6-K OBOOK HOLDINGS INC. For: Oct 14
-
Form 13F-HR StoryOne LLC For: Sep 30
-
Form 8-K Data443 Risk Mitigation, For: Oct 14
-
Form 8-K Vir Biotechnology, Inc. For: Oct 09
-
Form 13F-HR FULTON BANK, N.A. For: Sep 30
-
Form 6-K CORPORACION AMERICA AIRP For: Oct 14
-
Form 10-Q CytoDyn Inc. For: Aug 31
-
Form SC 14D9/A ACV Auctions Inc. Filed by: ACV Auctions Inc.
-
Form D/A McWilliams Capital Fund,
-
Form 6-K GLOBALFOUNDRIES Inc. For: Oct 14
-
Form 8-K Eagle Point Income Co For: Oct 14
-
Form SCHEDULE 13D Troops, Inc. /Cayman Filed by: Prime Ocean Holdings Ltd
-
Form 4 LESAKA TECHNOLOGIES INC For: Aug 03 Filed by: Mazanderani Ali
-
Form 8-K Datacentrex, Inc. For: Oct 14
-
Form 8-K Coya Therapeutics, Inc. For: Oct 14
-
Form 6-K Biodexa Pharmaceuticals For: Oct 14
-
Form 3 M Evo Global Acquisition For: Oct 06 Filed by: Majlinder Jan Richard
-
Form 6-K BUUU Group Ltd For: Oct 14
-
Form 6-K Nuran Wireless Inc. For: Oct 14
-
Form 4 EuroDry Ltd. For: Oct 13 Filed by: Pittas Aristeidis P
-
Form D Cahero Korva Holding
-
Form DEFM14A Bowhead Specialty Holdin
-
Form 13F-HR HELIOS CAPITAL MANAGEMEN For: Sep 30
-
Form 424B2 CITIGROUP INC
-
Form 13F-HR Physician Wealth Solutio For: Sep 30
-
Form D Gaingels Weave LLC
-
Form D Cahero Nytra Holding
-
Form SC TO-I/A Medtronic plc Filed by: Medtronic plc
-
Form DEFA14A FLEX LTD.
-
Form 8-K Valion Bio, Inc. For: Oct 14
-
Form 13F-HR TRAPHAGEN INVESTMENT For: Sep 30
-
Form D Gaingels Coverd LLC
-
Form 8-K FLEX LTD. For: Oct 09
-
Form 6-K NatWest Group plc For: Oct 14
-
Form 8-K MAXCYTE, INC. For: Oct 14


